2 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Synflorix: new trials by email Literature Review of Synflorix trials Research Report on Synflorix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV RSV (GSK3389245A) lower dose formulation vaccine, RSV (GSK3389245A) higher dose formulation vaccine, GSK's multicomponent meningococcal B vaccine - Respiratory Syncytial Virus Infections | Phase 1 / Phase 2 | Completed | GlaxoSmithKline | 201 | 2019-04-08 | 2022-07-27 |
| Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers PATH-wSP, Synflorix, Pentavac - Pneumonia, Pneumococcal | Phase 1 / Phase 2 | Completed | PATH | 304 | 2014-04-01 | 2019-10-10 |
Pneumonia, Pneumococcal (1) · Respiratory Syncytial Virus Infections (1)
GlaxoSmithKline (1) · PATH (1)
Brazil (1) · Canada (1) · Colombia (1) · Finland (1) · Italy (1) · Kenya (1) · Mexico (1) · Panama (1) · Poland (1) · Spain (1) · Thailand (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)
2018 (1)